Carcell Biopharma is a pre-clinical biotech company that promotes the development of next-generation cell and gene therapies.
Carcell Biopharma's investors include Legend Star, BioTrack Capital, Wuxi Capital, Hyfinity Investments, Jiayi Investment.
Carcell Biopharma is headquartered in Singapore, Singapore.
Carcell Biopharma is a pre-clinical biotech company that promotes the development of next-generation cell and gene therapies.
Carcell Biopharma is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Carcell Biopharma — Funding & Investors." VCBacked, November 13, 2023, https://www.vcbacked.co/company/carcell-biopharma. Accessed November 15, 2026.
VCBacked. (2023). Carcell Biopharma — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/carcell-biopharma
{{cite web |title=Carcell Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/carcell-biopharma |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Carcell Biopharma? Request a listing update